In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market insights reveal exciting opportunities. See more.

Brain Atrophy in MS Brain volume measurements are not used in routine clinical practice, but it is a very attractive MRI metric in MS because it is clinically relevant, robust and could offer an ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

Understanding the risks of cross-sex hormone therapy is important not only for clinicians and patients but also for ...

"The kids pick up on my stress, no longer feel safe, and head straight into fight or flight. They shout, I shout, someone ...

Roche to advance prasinezumab into phase III development for early-stage Parkinson's disease: Basel Tuesday, June 17, 2025, 09:00 Hrs [IST] Roche announced its decision to proceed ...

Background Neuroaxonal loss occurs in the early stages of multiple sclerosis (MS), but whether it results from early inflammatory brain damage or an ongoing neurodegenerative process remains unclear.

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...